Anavex Life Sciences Corp.

Anavex Life Sciences Corp.verified

AVXL

Price:

$8.3

Market Cap:

$703.80M

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinical clinical trials to treat epilepsy, infantile spasms, Fragile X syndrome, Angelman syndrome, multiple sclerosis, and tuberous sclerosis complex. The company's drug candidate also comprises ANAVEX 3-71, which is in Phase I clinical trial for the trea...[Read more]

Industry

Biotechnology

IPO Date

2006-08-02

Stock Exchange

NASDAQ

Ticker

AVXL

The Current Ratio as of December 2024 (TTM) for Anavex Life Sciences Corp. (AVXL) is 12.04

According to Anavex Life Sciences Corp.’s latest financial reports and current stock price. The company's current Current Ratio is 12.04. This represents a change of -6.16% compared to the average of 12.83 of the last 4 quarters.

Anavex Life Sciences Corp. (AVXL) Historical Current Ratio (quarterly & annually)

How has AVXL Current Ratio performed in the past?

The mean historical Current Ratio of Anavex Life Sciences Corp. over the last ten years is 7.99. The current 12.04 Current Ratio has changed 14.97% with respect to the historical average. Over the past ten years (40 quarters), AVXL's Current Ratio was at its highest in in the March 2022 quarter at 19.86. The Current Ratio was at its lowest in in the September 2016 quarter at 2.96.

Quarterly (TTM)
Annual

Average

7.99

Median

6.04

Minimum

2.96

Maximum

14.97

Anavex Life Sciences Corp. (AVXL) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Anavex Life Sciences Corp. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 2.43%

Maximum Annual Current Ratio = 14.97

Minimum Annual Increase = -49.08%

Minimum Annual Current Ratio = 2.96

Quarterly (TTM)
Annual
YearCurrent RatioChange
202312.32-17.62%
202214.95-0.10%
202114.97216.54%
20204.73-5.93%
20195.03-19.73%
20186.26-19.23%
20177.75161.83%
20162.96-49.08%
20155.8113.98%
20145.102.43%

Anavex Life Sciences Corp. (AVXL) Average Current Ratio

How has AVXL Current Ratio performed in the past?

The current Current Ratio of Anavex Life Sciences Corp. (AVXL) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

14.08

5-year avg

10.40

10-year avg

7.99

Anavex Life Sciences Corp. (AVXL) Current Ratio vs. Peers

How is AVXL’s Current Ratio compared to its peers?

Anavex Life Sciences Corp.’s Current Ratio is greater than Cassava Sciences, Inc. (3.55), greater than INmune Bio, Inc. (2.59), greater than BioVie Inc. (2.95), greater than Cognition Therapeutics, Inc. (2.11), greater than Annovis Bio, Inc. (2.66), greater than Iovance Biotherapeutics, Inc. (4.22), greater than Axsome Therapeutics, Inc. (2.44), greater than Novavax, Inc. (0.93), greater than Exelixis, Inc. (3.93), greater than TG Therapeutics, Inc. (4.59), less than Viking Therapeutics, Inc. (36.47), greater than Madrigal Pharmaceuticals, Inc. (5.98), greater than BioXcel Therapeutics, Inc. (1.87), greater than Reviva Pharmaceuticals Holdings, Inc. (0.39), greater than Eyenovia, Inc. (0.74), greater than TransCode Therapeutics, Inc. (1.58), greater than Kodiak Sciences Inc. (8.42),

Build a custom stock screener for Anavex Life Sciences Corp. (AVXL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Anavex Life Sciences Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Anavex Life Sciences Corp. (AVXL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Anavex Life Sciences Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Anavex Life Sciences Corp.'s Current Ratio?

How is the Current Ratio calculated for Anavex Life Sciences Corp. (AVXL)?

What is the highest Current Ratio for Anavex Life Sciences Corp. (AVXL)?

What is the 3-year average Current Ratio for Anavex Life Sciences Corp. (AVXL)?

What is the 5-year average Current Ratio for Anavex Life Sciences Corp. (AVXL)?

How does the current Current Ratio for Anavex Life Sciences Corp. (AVXL) compare to its historical average?